Earlier quoted context omitted.
Typically what happens is that the new treatments with bad side effects are given to the sickest patients (who have exhausted all other mechanisms), rather than to the bravest souls with less dire current circumstances. This makes some sense in terms of compassion and matching new experimental techniques with patients with no hope, but it skews the results highly negative because the patients are already very close t…
> I don't think any of this can be changed without large-scale social acceptance of greater risk in clinical trials and significant support from the government. I agree with you about significant financial support from the government if that support is financial and given to smaller groups. I disagree about societal acceptance though. I feel like your point of view may be missing clinical trials and treatments in the…
CRISPR tech selectively shreds cancer cells, including "undruggable" cancers
231–239 of 239 posts
Re: CRISPR tech selectively shreds cancer cells, including "undruggable" cancers
#232Re: CRISPR tech selectively shreds cancer cells, including "undruggable" cancers
#233Apoptosis: cell death.
Re: CRISPR tech selectively shreds cancer cells, including "undruggable" cancers
#234Re: CRISPR tech selectively shreds cancer cells, including "undruggable" cancers
#235Apoptosis: cell death.
[1]: https://www.cambridge.org/core/books/abs/reproduction/galens...
Re: CRISPR tech selectively shreds cancer cells, including "undruggable" cancers
#236Earlier quoted context omitted.
In practice, you’d use multiple guides targeting multiple mutations, so that the probability of having/acquiring multiple resistance mutations abrogating every guide from binding would be infinitesimal.
LNPs have limited capacity, and if the CRISPR/Cas system they’re using requires an exact match, then any additional point mutation or insertion or deletion in the segment being matched would allow the cell to survive. I suppose that approximately 3n extra guide RNAs (where n is the length of the matched sequence) could be added, but that seems a bit messy.
Re: CRISPR tech selectively shreds cancer cells, including "undruggable" cancers
#237Earlier quoted context omitted.
I don't mean to sound insensitive, but don't most people die around age 70-80?
Life expectancy in many countries is mid 80s.
Re: CRISPR tech selectively shreds cancer cells, including "undruggable" cancers
#238Earlier quoted context omitted.
Typically what happens is that the new treatments with bad side effects are given to the sickest patients (who have exhausted all other mechanisms), rather than to the bravest souls with less dire current circumstances. This makes some sense in terms of compassion and matching new experimental techniques with patients with no hope, but it skews the results highly negative because the patients are already very close t…
> It does not provide an accurate signal for what the results would be if we gave them to less sick people. It provides an excellent signal because we want to prove that these drugs are doing something that the standard of care is unable to. There's this sense that medicine is easy and some evil cabal are limiting health to their cronies. Most medications never get to trial for their intended indications, and most fa…
Re: CRISPR tech selectively shreds cancer cells, including "undruggable" cancers
#239Earlier quoted context omitted.
You say my claim is not true then proceed to acknowledge it is true. To be clear about the fact: about 1/4 of all countries have a life expectancy >80, and as you said, more than a dozen in mid-80s.
Well, no, no country on earth has an expectancy in the mid 80s, I was being generous with your wording. 40-50 countries have expectancy between 80-84, which is early 80s. Most countries are sub-80.
My original statement was that life expectancy in many countries is in the mid-80s. Which is, in fact, true.
If you want to split hairs about what constitutes “mid”, you can, but I doubt many people would agree with you that age 84 does not qualify as “mid-eighties”.